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Several types of active-site-directed inactivators (inhibitors) of the Zn2+-containing
D-alanyl-D-alanine-cleaving carboxypeptidase were tested. (i) Among the heavy-
atom-containing compounds examined, K2Pt(C204)2 inactivates the enzyme with a
second-order rate constant of about 6 x 10-2M-1 . 1 and has only one binding site
located close to the Zn2+ cofactor within the enzyme active site. (ii) Several
compounds possessing both a C-terminal carboxylate function and, at the other end of
the molecule, a thiol, hydroxamate or carboxylate function were also examined.
3-Mercaptopropionate (racemic) and 3-mercaptoisobutyrate (L-isomer) inhibit the
enzyme competitively with a Ki value of 5 x 10-9-10 x 10-9M. (iii) Classical P-lactam
compounds have a very weak inhibitory potency. Depending on the structure of the
compounds, enzyme inhibition may be competitive (and binding occurs to the active
site) or non-competitive (and binding causes disruption of the protein crystal lattice).
(iv) 6-,B-Iodopenicillanate inactivates the enzyme in a complex way. At high P-lactam
concentrations, the pseudo-first-order rate constant ofenzyme inactivation has a limit
value of 7 x 10-4s- 1. 6-p-Iodopenicillanate binds to the active site just in front of the
Zn2+ cofactor and superimposes histidine-190, suggesting that permanent enzyme
inactivation is by reaction with this latter residue.
The transpeptidation and carboxypeptidation
reactions involved in the last stages of wall
peptidoglycan synthesis in bacteria are catalysed
by multiple D-alanyl-D-alanine-cleaving peptidases
(in short DD-peptidases) (Ghuysen et 'al., 1981).
The serine DD-carboxypeptidases/transpeptidases
operate via acyl-enzyme formation and are sus-
ceptible to inactivation by P-lactam antibiotics.
One of them has been crystallized and the
penicillin-binding site has been located (Kelly et
al., 1982). A metallo DD-peptidase is also known
that requires a Zn2+ cation bound to the active site
for catalysis (Dideberg et al., 1980b). This enzyme
functions solely as a carboxypeptidase and is
highly resistant to penicillins and cephalosporins
(Ghuysen et al., 1981). Its primary structure (Joris
et al., 1983) and crystal structure at 0-25nm (2.5 A)
resolution (Dideberg et al., 1982)- are known.
Attempts were made tofjind effective inhibitors
(inactivators) of the Zn2+ pn-carboxypeptidase.
The results obtained during this first exploratory
phase are described below.
Materials and methods
,B-Lactam compounds
Cephalosporin C, cephalothin and cephalo-
glycine were from Eli Lilly and Co., Indianapolis,
IN, U.S.A. The P-iodopenicillanate was a gift from
Dr J. T. Henderson and Dr. J. E. G. Kemp from
Pfizer Central Research, Sandwich, Kent, U.K.;
7 - [2 - (p - iodophenyl)acetamido]cephalosporanate
was that previously used (Dideberg et al., 1982)
and was synthesized by Dr. L. Christiaens,
Department of Organic Chemistry, University of
Lege.
Heavy-metal-containing compounds
K3UO2F5 was a gift from Dr. D. Stuart, Oxford,
U.K. K2PtCl4, (NH4)2IrCl6 and NaAuCl4 were
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from Aldrich Chemical Co., Milwaukee, WI,
U.S.A., NaUO2(CH3CO2)3 was from Merck,
Darmstadt, Germany, and K2Pt(C204)2 was syn-
thesized as described in Pascal (1958).
Zn2+-directed inactivating reagents
Compounds (2), (3), (4) and (10) of Fig. 4 (see the
Results section) were generously given by Dr. M.
Ondetti of the Squibb Institute for Medical
Research, Princeton, N.J., U.S.A. Compounds (1),
(5), (6), (7), (8), (9) and (11) were from Aldrich
Europe Division, Janssen Pharmaceutica N.V., B-
2340 Beerse, Belgium. Compounds (12), (13) and
(14) were synthesized during the present work.
Buffers
Buffer A was 10mM-Tris/HCl, pH 8.3, contain-
ing 5mM-MgCl2, and buffer B was 10mM-Hepes
[4-(2-hydroxyethyl)-1-piperazine-ethanesulphonic
acid]/NaOH, pH8.0, containing 5mM-MgCl2.
Enzyme
The Zn2+ DD-carboxypeptidase was purified to
protein homogeneity as described in Duez et al.
(1978). The enzyme activity was determined by
incubating the enzyme with 1.8 mM-N"Nt-diacetyl-
L-lysyl-D-alanyl-D-alanine at 37°C in a total volume
of 30Ml of either buffer A or buffer B and
measuring enzymically the amount of C-terminal
D-alanine liberated (Frere et al., 1976; De Coen et
al., 1981).
Interaction between the Zn2+ DD-carboxypeptidase
and P-lactam compounds (Frere et al., 1978)
The P-lactam compounds react with the enzyme
according to:
lactam compound by dialysis, A, is the activity
after incubation of the enzyme- -lactam complex
E-I* at 37°C, and A is the activity of an enzyme
sample treated as above but without P-lactam
compound).
Determination of the apparent rate constants (ka
values) for the formation of complexes E-I* and K
and k+2 values. The enzyme (3.4Mm) and the JJ-
lactam compound (at concentrations ranging from
1 to 15mM) were incubated together at 37°C in 60 1
of buffer B. Formation of complex E-I* was
determined on 1 MI samples removed after increas-
ing times of incubation (and further incubated for
15 min at 37°C with 1.8 mM-Ac2-L-Lys-D-Ala-D-
Ala). Plots of ln (A,/Ao) versus time yielded
straight lines (A, is the residual enzyme activity at
time t and Ao is the initial enzyme activity),
permitting calculation of ka. Plots of ka versus [I]
showed deviation from linearity at high [I] values.
Individual values ofK and k+2were obtained from
the reciprocal plots l/ka versus 1/[I].
Effect of the presence of Ac2-L-Lys-D-Ala-D-Ala.
The enzyme (1.2Mm), the f-lactam compound (at
concentrations ranging from 0.05 to 10mM) and
Ac2-L-Lys-D-Ala-D-Ala (at concentrations ranging
from 0.275 to 1.1 mM) were incubated together for
2min at 37°C in 100I of buffer A, and the amount
of released D-Ala was determined. Lineweaver-
Burk plots (1/v versus 1/[S] for various [I] values)
allowed determination of the type of enzyme
inhibition (competitive or non-competitive).
Interaction between the Zn2+ DD-carboxypeptidase
and non-fi-lactam inhibitors (inactivators)
All the experiments were performed in buffer A.
E+I K' E .I k- 2. E-I* -' E + degradation product(s)
where E is enzyme, I is fl-lactam compound, E-I*
is inactive complex, K is the dissociation constant
and k+2 and k+3are first-order rate constants. The
Zn2+ DD-carboxypeptidase shows high intrinsic
resistance to all fl-lactam compounds tested be-
cause of low k+2/K values.
Determination of the k+3 values. The enzyme
(33 gM) and the P-lactam compound (20mm) were
incubated together for 2h at 37°C in 25Ml of buffer
B. The reaction mixture was 100-fold diluted in
buffer B, dialysed against the same buffer for 2h at
4°C and then incubated at 37°C. Samples were
removed after increasing times of incubation, and
the extent of enzyme recovery (or breakdown of
complex E-I*) was determined after an additional
incubation of 15min at 37°C with 1.8mM-Ac2-L-
Lys-D-Ala-D-Ala. Plots of ln [1-(A, -AO)/(A - AO)]
versus time gave rise to straight lines (Ao is the
residual activity after removal of the unbound f,-
As a first approximation, the inhibiting (inactivat-
ing) potency of a compound was expressed by the
concentration necessary to decrease the enzyme
activity by 50% (ID50 value) when enzyme,
substrate and inhibitor were incubated together at
37°C. Pseudo-first-order rate constants (ka) of
enzyme inactivation were determined as indicated
above. Lineweaver-Burk plots and Dixon plots
(1/v versus [I] for various [S] values) were used to
determine the type of enzyme inhibition and to
measure the Ki values.
Enzyme crystals
Crystallization of the Zn2+ DD-carboxy-
peptidase was carried out as described in Dideberg
et al. (1979).
Preparation of enzyme crystal derivatives
A cell consisting of two microscope slides with
depressions as shown in Fig. 1, and fixed to each
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Fig. 1. Schematic representation of the cell usedfor the preparation ofcomplexes of the Zn2+ DD-carboxypeptidase crystal
For further details see the text.
7.5 16 33 45
I,-Iodopenicillanatel (mM)
Fig. 2. Relative variation ofthe birefringence ofa crystal of
the Zn2+ DD-carboxypeptidase as a function of increasing
concentrations of J-iodopenicillanate
AB/B is the relative variation of birefringence.
Diffusion of ,-iodopenicillanate was carried out
within a total period of time of 24h. I-lodo-
penicillanate was added stepwise after 30min (1),
90min (2), 180min (3), 270min (4), 18h (5), 20h (6)
and 24h (7). For further details see the text.
other by a rubber joint, was used. Before the cell
was mounted, an enzyme crystal (of thickness
0.05mm) and a 30pl sample of mother liquor were
deposited in the left-hand well, and another 30pl
sample ofmother liquor was deposited in the right-
hand well. The two droplets were connected by a
thin liquid bridge by means of a fine needle. After
the cell had been sealed, a solution of the selected
compound (heavy atom or organic inhibitor) was
injected in the right-hand well and the compound
concentration was increased stepwise, the system
being allowed to equilibrate between each step.
Formation of the enzyme derivative was moni-
tored by measuring the changes in birefringence of
the crystal with time, with a Berek compensator.
Fig. 2 shows the results obtained with fi-iodo-
penicillanate. All the above operations were
performed at 200C.
X-ray-diffraction studies
The experiments were performed with a Hilger-
Watts diffractometer fitted with an He-filled
tunnel and with the use of Ni-filtered Cu K.
radiation (40kV, 26mA). Absorption corrections
were deduced from scans (North et al., 1981),
and the decreased intensity due to radiation
damage was corrected by a time function. The
maximum decay correction was 20%. The posi-
tions of the heavy atoms were determined from
FHLE Patterson functions, and parameters were
refined by a least-squares procedure. For the
complexes formed with Pt(C204)2-, U02F53 -
and AuCl4-, the process was followed by three
cycles of phase refinement at 0.25nm resolution.
The crystal data for the native enzyme and for
the enzyme-,B-iodopenicillanate complex are given
in Table 1. The complete 0.28nm data set (hkl and
h1cl) was measured on one crystal. The structure
factor amplitudes of the enzyme-,B-lactam com-
plex were scaled to those of the native enzyme. The
Rdif. factor was 0.11. A difference electron-density
map was computed from the coefficients
mI Fcj-IFpj and the multiple isomorphous-
replacement phases (Dideberg et al., 1982). Reflex-
ions of resolution lower than 1 nm were omitted
from these summations.
Results
Inactivation of the Zn2+ DD-carboxypeptidase by
heavy-metal-containing compounds
Pseudo-first-order kinetics of enzyme inactiva-
tion were observed with (NH4)2IrCl6, NaAuCl4,
K2Pt(C204)2 and K2PtCl4. The corresponding
second-order rate constants were 2.4x 10-2,
5.7x 10-2, 6.2x 10-2 and 18.6x 10-2M-1- 1
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Table 1. Crystal data for the native Zn2 + DD-carboxypeptidase and the complex formed with P-iodopenicillanate
Rsym = ZZIIi -7h1I/1IIh
h h
where Iid is the intensity of an hkl reflexion and 7h is the mean intensity.
Rdif. =EIIF - IFplIl/ZlFpl
where IFJI is the structure-factor amplitude of the f-iodopenicillanate-Zn2 + DD-carboxypeptidase complex and IFpI that



















Table 2. Position of heavy atoms in the Zn2 + DD-carboxypeptidase crystal structure
Site no. (as Relative


















Active site, close to Zn2+ and His-190
Between Cys-140 of one enzyme molecule and Asp-39 of a second
enzyme molecule
Close to Met-153
Active site, close to Zn2+ and His-190
Between the side chains of Met-124 and Glu-165
Active site, close to Zn2+ and His-190
Close to His-177
Close to Asp-62
Active site, close to His-152 and Asn-141
[20mM-NaUO2(CH3CO2)3 and 30mM-K3UO2F5],
rapid but partial enzyme inactivation (35% and
25% respectively) occurred during the first 5-
10min of incubation. During subsequent incuba-
tion, enzyme inactivation by NaUO2(CH3CO2)3
continued to proceed, but at a very low rate
(O.93xlO-2M-1'-s1). K3UO2F5 had no further
detectable effect, at least within 60min of
treatment.
The positions of the aforementioned heavy
atoms [except (NH4)2IrCl6 and NaUO2Ac3] in the
Zn2+ DD-carboxypeptidase and the relative occu-
pancies of the binding sites were determined
(Table 2 and Fig. 3). Compound K2Pt(C204)2
gave rise to one single binding site, which was
located within the enzyme cavity. The other heavy-
atom-containing compounds gave rise to multiple
(two to four) binding sites, but in each case only
one of these was also located within the enzyme
active site.
Compound K2PtCi4 was the most potent inacti-
vator (as expressed by the second-order rate
constant of enzyme inactivation), although bind-
ing to the active site was rather weak (as expressed
by the relative occupancy value). However,
K2PtCl4 was the only heavy-atom-containing
compound that occupied four distinct binding
sites, and the enzyme-K2PtCl4 derivative was the
only one that showed lack of isomorphism.
Attempts to construct 'bi-product' analogue
inactivators
A general application of the concept of 'bi-
product' analogues (Byers & Wolfenden, 1972)
makes use of functional groups able to interact
regio- and stereo-specifically with the different
enzyme binding areas and to anchor the molecule
firmly within the enzyme active site. This ap-
proach led to the synthesis of specific inhibitors of
the Zn2+-containing carboxypeptidases A and B,
thermolysin and angiotensin-converting enzyme
(Cushman et al., 1977).
The Zn2+ DD-carboxypeptidase active site prob-
ably possesses at least three subsites (Fig. 4).
Subsites S2, SI and, with a less strict requirement,
subsite S' must be suitably complemented by the
substrate side chains, and Arg-136 is probably
involved in charge-pairing. Several bifunctional
compounds were tested (Fig. 4). Most of the active
compounds possessed a C-terminal carboxylate
function capable of binding to the cationic centre
Arg-1 36, and either a thiol, hydroxamate or
carboxylate function capable of binding to the
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Fig. 3. Stereoscopic view of the three-dimensional structure of the Zn2+ DD-carboxypeptidase
The a-carbon-positions were derived from a Kendrew model. For the labelling of the heavy-atom-binding sites, see
Table 2. The amino acid residues were designated by the one-letter code (IUPAC-IUB Commission on Biochemical
Nomenclature, 1969). Numbering of the amino acid residues is that derived from X-ray data (Dideberg et al., 1982).
At present, there are still minor discrepancies between this sequence and that derived from chemical and enzymic
degradation (Joris et al., 1983). Strong experimental evidence suggests (i) that His-152, His-193 and His-196 serve as
Zn2+ ligands, (ii) that charge-pairing may occur between the C-terminal carboxylate function ofthe bound substrate
and Arg-136, and (iii) that His-190 may play the role of a proton donor in catalysis. The model was drawn with the
use of the Packgraph programme (Katz & Levinthal, 1972).
bones of the compounds were too short to permit
interaction with subsites S, and S2. Unless
otherwise specified, racemic compounds were
used. From this preliminary exploration, the
following are apparent.
1. Inactivating potency requires a C-terminal
anionic group [compare compounds (13) and (14)]
and greatly depends on the nature of the function
that is directed towards the Zn2+ cofactor. The
comparable pairs compounds (1) and (12) and
compounds (2) and (11) showed that replacing a
thiol by a hydroxamate or a carboxylate at this
position caused a 1000-fold and 100000-fold
decreased affinity respectively.
2. As shown by Lineweaver-Burk plots of l/v
versus 1/[S] for various concentrations of I (where v
is the initial velocity of substrate consumption, S is
the substrate Ac2-L-Lys-D-Ala-D-Ala and I is the
inactivator), compounds (1)-(5) were potent com-
petitive inhibitors. Contrary to the expectations,
comparable effectiveness was achieved whether
the lateral chain assumed to complement subsite S;
was a proton, a methyl group in the L configuration
or a methyl group in the D configuration, and
whether one single or two carbon atoms were
disposed between the terminal thiol and carboxy-
late functions. Moreover, the most potent inactiva-
tors were 3-mercaptopropionate (Ki = 5 x 10- 9M)
and the L-isomer of 3-mercaptoisobutyrate
(Ki= 10 x 10-9M), whereas the D-isomer of 3-
mercaptoisobutyrate was somewhat but distinctly
less potent (Ki = 60 x 10-9M). Such small truncat-
ed molecules did not offer the possibility of com-
plementing subsites SI and S2, and, as the above
observations strongly suggested, subsite S; alone
seemed not to play any significant role in the
binding process. Considering the flexibility of
these molecules, enzyme inactivation may be
caused by bidentate interaction with formation of
a penta- or hexa-co-ordinate Zn2+ ion (Fig. 5).
3. As models showed, folding the above mole-
cules to form a penta- or hexa-co-ordinate Zn2+ ion
oriented the lateral chain towards His-190, which
may play the role of proton donor in catalysis. A
methyl group, especially in an L configuration, had
no prominent steric effect, but more bulky substi-
tuents on the a-carbon atom [compounds (6)-(10)]
were much less favourable, thus considerably
decreasing the binding efficacy.
4. Alternative mechanisms for the loss of
enzyme activity on treatment with 3-mercaptopro-
pionate were envisaged. One of them might have
been by opening of the disulphide bridges [which
occur in three places in the protein (Dideberg et al.,
1982; Joris et al., 1983)]. This possibility was
eliminated by the following experiment. The
enzyme (1.1 M) and the inhibitor (100 tM) were
incubated together for 5min at 37°C in buffer A,
which treatment caused complete enzyme inhi-
bition. The reaction mixture was then supple-
mented with 1 mm-dithiobis-2-nitrobenzoate,
which caused enzyme recovery with a first-order
rate constant of about 6.4 x 10-4s 1 (90% recovery
was observed after 60min). Another alternative
was that loss of enzyme activity might have been
by removal of the Zn2+ cofactor from the active
site by the inhibitor. In turn, this possibility was
eliminated by the following experiment. The
enzyme (5nM) and the inhibitor (100nM) were
incubated together at 37°C in buffer A until 80% of
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3 x 1 0-3
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No activity
Fig. 4. Positioning ofthe tripeptide Ac2-L-Lys-D-Ala-i-Ala in the ac#tv site ofthe Zn2+ DV-carboxypeptWdase and inhibittn
potency of bifunctional compounds
ID50 is defined in the Materials and methods section. With compounds (1)-(5) the enzyme (Sum) and the inhibitor
(10-200nM) were incubated for 60min. With compounds (6)-(10) and (12) the enzyme (0.8yM) and the inhibitor
(33 pm-1 mM) were incubated for 5min. With compounds (11), (13) and (14) the enzyme (0.8.pm) and the inhibitor
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His-i 93
H is- 1 52 His-196\/
Zn2+
-s
Fig. 5. Possible bidentate interaction between the Zn2+ DD-
carboxypeptidase and a bifunctional (thiol/carboxylate)
inhibitor
the initial activity had disappeared (i.e. after
5 min). The reaction mixture was then supple-
mented with 120nM-ZnSO4, i.e. at a concentration
much higher than that of 3-mercaptopropionate,
which treatment failed to regenerate an active
carboxypeptidase.
Inactivation by bicyclic ring-fused azetidinone
structures
(a) Classicalpenams and 3-cephems. On the basis
of reaction (1) (see the Materials and methods
section), the lower the K value and the higher the
k+2 and k+ 3values, the more potent a P-lactam as
an enzyme inactivator. Although, once formed,
complexes E-I* are very stable (low k+3 values),
the 6-f-substituted penicillins were found to be
extremely poor inactivators of the Zn2+ DD-
carboxypeptidase because of very high K values
and very low k+2 values (150mM and 8 x 10-4s-1
respectively for phenoxymethylpenicillin, which is
the most potent penam inactivator so far tested)
(Frere et al., 1978). The 7-p-substituted cephalo-
sporins were somewhat better inactivators, mainly
because of more favourable K values (1-10mM).
Lineweaver-Burk plots showed that 7-fl-
substituted A3-cephems fall into two groups.
Cephalothin (K= 9.5mM; k+2 = 5 x 10-4S-1;
k+3=5x10-6s- ; in buffer B) and cephalo-
sporin C (K=2mM; k+2= 1 x 10-4s-I;
k+3=2x10-6s- ; in buffer B) acted non-com-
petitively. In parallel to this, cephalothin (10mM)
and cephalosporin C (1.66mM) destroyed the
crystal lattice, thus preventing any study from
being carried out by X-ray diffraction. In contrast,
cephaloglycine (K=4.5mM; k+2=3x 10-4s-I;
k+3 =9x 10-6S-1; in buffer B) and 7-[2-(p-iodo-
phenyl)acetamido]cephalosporanate (K = 3.5mM;
k+2 = 6 x 10-4s- l; k+3 = 1+ 10-6s-1; in buffer
A) acted competitively. The enzyme complex
formed with this latter compound showed satisfac-
tory isomorphism and indicated that the f-lactam
was bound to the active site (Dideberg et al., 1980a,
1982).
(b) P-Iodopenicillanate. 6-p-Halogenopenams are
f-lactamase inactivators, and, in this respect, 6-p-
iodopenicillanate has been much studied (Frere
et al., 1982, and other references included in
that paper). Kinetically, the interaction between
the Zn2+ DD-carboxypeptidase and 6-p-iodo-
penicillanate was found to resemble that observed
with the ,B-lactamases, in that complete and
permanent inactivation was observed only at high
(> 12500) inactivator/enzyme ratio. When this
ratio was decreased, enzyme inactivation was
incomplete, and, after subsequent prolonged incu-
bation, partial and spontaneous recovery of en-
zyme activity was observed. Although more work
remains to be done in order to elucidate the under-
lying mechanism, these observations suggested a
branched pathway including (i) normal turnover
through an intermediate E-I*, (ii) re-arrangement
of this intermediate into a transitorily inactive
complex E-I**, and (iii) re-arrangement of the
same intermediate into a permanently inactive
complex E-I*** (see Fig. 6 legend). The first
phases of enzyme inactivation by increasing
concentrations of P-iodopenicillanate proceeded
according to pseudo-first-order kinetics. From the
ka values thus obtained, a Hanes plot, [I]/ka versus
[I], gave rise to a straight line (Fig. 6) intersecting
the ordinate axis at KIlka (limit) and the abscissa axis
at - Ki. From the slope (l/ka(limit)), a ka(limit) value
of 7 x 10-4s-1 was computed. The Ki value was
0.66mM.
An enzyme crystal was treated with ,B-iodo-
penicillanate as described in the Materials and
methods section. The [I]/[E] ratio was estimated to
be about 8300, and extensive inactivation oc-
curred. (Indeed, when the measurements described
below were completed, the treated crystal was
dissolved, and DD-carboxypeptidase assays carried
out on a sample of this solution showed that 85% of
the enzyme has been permanently inactivated.)
The enzyme derivative was perfectly isomorphous,
and the difference Fourier synthesis at 0.28nm
resolution gave one main peak that was much
higher than any other features of the map. The
shape and the height of the peak did not
correspond to an iodine atom with a full occu-
pancy, strongly suggesting that iodine had been
eliminated. The site of interaction clearly extended
from His-190 just in front of the Zn2+ cofactor
(Fig. 7) to an open cavity formed by the two
segments His-190-Gly-189-Pro-188 and Asn-141-
Ser-Asn-Val-144-Gly-Gly-Ala-147. These obser-
vations strongly suggest that, in the process of
permanent inactivation of the Zn2+ DD-carboxy-
peptidase by 6-f-iodopenicillanate, the catalytic-
ally active His-190 was alkylated with loss of I-.
Such a mechanism would drastically differ from
the inactivation of the serine ,B-lactamases, whose
serine residue is irreversibly acylated by P-bromo-
(iodo)penicillanate (Cohen & Pratt, 1980). A minor
peak was also found in the difference map close to
Arg-1 36. The shape and the size of the density
suggested that this peak was attributable to an ion.
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Fig. 6. Hanes plot for the interaction between the Zn2+ DD-carboxypeptidase and f-iodopenicillanate (1)




where P and P E E-I* dg ai prE-I**dc thE+Pe
\E-I***
where P and P' = degradation products, then:
I k+2 + k+3
and
ka(Iim) k+2(k+4 + k+5)
Discussion
Non-f,-lactam bifunctional reagents may be
potent competitive inhibitors of the Zn2+ DD-
carboxypeptidase. Enzyme inactivation by these
agents (see Fig. 4) cannot be attributed to cleavage
of the disulphide bridges and subsequent dis-
organization of the protein three-dimensional
structure, nor to the detachment of the Zn2+ ion
from the active site. Most probably it is due to the
immobilization of the Zn2+ cation by co-ordina-
tion, thus preventing the cofactor from performing
its catalytic function. The bifunctional compounds
so far examined complement only part of the
binding sites of the enzyme active site. Specificity
and perhaps increasing inactivating potency re-
quires more elaborate structures that not only
would firmly anchor the inhibitor molecules in the
active site but would be apt to interact specifically
with the SI and S2 subsite targets.
Classical P-lactams are extremely poor inactiva-
tors (as well as substrates) of the Zn2+ DD-carboxy-
peptidase. Some of them (cephaloglycine and 7-[2-
(p-iodophenyl)acetamido]cephalosporanate) are
weak competitive inhibitors. X-ray-diffraction
studies have provided direct evidence that this
latter compound binds to the enzyme active site.
Other f,-lactams (cephalosporin C and cepha-
lothin) are weak non-competitive inhibitors. In
parallel to this, these compounds destroy the
protein crystal lattice and profoundly alter the
scattering behaviour of the protein by inducing
large conformational changes and/or aggregation
(Labischinski et al., 1984). 6-,B-Iodopenicillanate is
an unusual penam in that it has a very short side
chain. Its interaction with the Zn2+ D-carboxy-
peptidase is complex, but at high ,B-lactam concen-
trations it inactivates the enzyme with a pseudo-
first-order rate constant of 7 x 10-4s-i (limit
value). X-ray analysis shows that this P-lactam
compound is located in the enzyme active site just
in front of Zn2+ and superimposes His-190 (which
is thought to act as proton donor during catalysis of
a bound peptide substrate), suggesting that His-
190 acts as a nucleophile by its lone electron pair of
the nitrogen atom and undergoes alkylation by 6-f-
iodopenicillanate with loss of iodine.
The above studies strongly suggest that both the
high intrinsic resistance of the Zn2+ DD-carboxy-
peptidase to ,B-lactam compounds and the extreme-
ly low substrate activity of these ,B-lactam com-
pounds towards the Zn2+ DD-carboxypeptidase are
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Fig. 7. Difference electron density between the native Zn2+
DD-carboxypeptidase and its complex formed with P-iodo-
penicillanate, in the vicinity of the Zn2+-cofactor site
The contour levels, shown on an arbitrary scale with
maximal value of 10, are -5, 5 and 7. The contour of
negative value (-5) is shown as a broken line. The
unit cell was divided into 48 x 48 x 48 points. The
Figure is a composite of sections of Y= 19 to 24, and
the area shown extends from X= 38 to 48 and from
Z = 14 to 34. The sequences Tyr-187-Pro-188-Gly-
189-His-190 (as positioned in the Kendrew model)
are shown as bold lines.
caused, most probably, by a particular geometry of
the enzyme active site. Production of enzyme-
ligand associations of high productiveness occurs
only with carbonyl donor peptides (thus, for
example, the standard tripeptide substrate AC2-L-
Lys-D-Ala-D-Ala is hydrolysed with a turnover
number of 2.5s-1 at 37°C). In contrast, the fi-
lactam compounds are little predisposed to align
correctly with regard to the active functional
groups. In fact, models show that with these
compounds it is difficult to align simultaneously
both the P-lactam amide bond with the Zn2+ ion
and the C-terminal carboxylate with Arg-136
because of collisions with other side chains of the
enzyme active site (P. Charlier & 0. Dideberg,
unpublished work).
One way to resolve the crystal structure of a
protein by X-ray-diffraction methods rests upon
the preparation of heavy-atom complexes with this
protein. In this procedure, attachment of the heavy
atom to the protein should not perturb the atomic
arrangement of the crystal and should involve as
few amino acid side chains as possible (Blundell &
Johnson, 1976). Among the heavy-atom-contain-
ing compounds tested, K2Pt(C204)2 is remarkable
in that it has only one binding site, located within
the enzyme cavity, close to the Zn2+ cofactor and
the putative proton donor His-190. Inactivation
proceeds with a second-order rate constant of
about 6x 1-2M-1-S-1.
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